CEG
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 1.53 · operating margin 12%
- Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
- Timing Unavailable or mixed. No stored price series
ACHAT TOTAL: 1 500 titres (~417 930,90 $ US)
- Insiders
- CRANDALL ROGER W
- Total bought
-
$417,931
Avg buy (VWAP, 90d window) $278.62 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-08-11
- Last synced
-
2026-08-21 23:36:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-11 | CRANDALL ROGER W | Buy | 1,500 | $278.62 | $417,931 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-06
CEG combines a strong event catalyst (raised FY2026 guidance, 920 MW new power deals, AI-driven nuclear demand) backed by meaningful insider conviction ($417k buy) with solid liquidity (75) and improving fundamentals…
The first sentence of the analysis written for CEG on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 75.8% | 25.4% | 13.3% | 8.7% | 14.0% | |
| Ebit Margin | 15.8% | 18.1% | 6.9% | 2.0% | 6.2% | |
| Ebitda Margin | 19.6% | 29.6% | 16.9% | 12.0% | 19.4% | |
| Operating Profit Margin | 12.1% | 18.5% | 6.5% | 2.0% | -1.8% | |
| Pretax Profit Margin | 13.8% | 19.1% | 9.8% | -2.3% | 0.7% | |
| Continuous Operations Profit Margin | 9.1% | 15.9% | 6.3% | -0.7% | -0.4% | |
| Net Profit Margin | 9.1% | 15.9% | 6.5% | -0.7% | -1.0% | |
| Bottom Line Profit Margin | 9.1% | 15.9% | 6.5% | -0.7% | -1.0% | |
| Current Ratio | 1.526 | 1.574 | 1.313 | 1.194 | 0.998 | |
| Quick Ratio | 1.307 | 1.340 | 1.076 | 1.002 | 0.837 | |
| Solvency Ratio | 0.078 | 0.164 | 0.105 | 0.064 | 0.065 | |
| Cash Ratio | 0.472 | 0.441 | 0.058 | 0.054 | 0.063 | |
| Price To Earnings Ratio | 47.739 | 18.799 | 23.285 | -176.732 | -66.922 | |
| Price To Earnings Growth Ratio | -1.262 | 0.137 | -0.021 | 7.934 | 0.496 | |
| Forward Price To Earnings Growth Ratio | -1.262 | 0.137 | -0.021 | 7.934 | 0.496 | |
| Price To Earnings Diluted Ratio | 47.739 | 18.799 | 23.331 | -176.732 | -66.922 | |
| Price To Earnings Diluted Growth Ratio | -1.262 | 0.137 | -0.021 | 7.934 | 0.496 | |
| Price To Book Ratio | 7.617 | 5.352 | 3.456 | 2.566 | 1.223 | |
| Price To Sales Ratio | 4.331 | 2.990 | 1.515 | 1.157 | 0.698 | |
| Price To Free Cash Flow Ratio | 85.849 | -14.012 | -4.889 | -6.996 | -5.144 | |
| Price To Operating Cash Flow Ratio | 26.097 | -28.599 | -7.122 | -12.017 | -10.254 | |
| Debt To Assets Ratio | 0.157 | 0.159 | 0.182 | 0.123 | 0.170 | |
| Debt To Equity Ratio | 0.619 | 0.639 | 0.848 | 0.524 | 0.731 | |
| Debt To Capital Ratio | 0.382 | 0.390 | 0.459 | 0.344 | 0.422 | |
| Long Term Debt To Capital Ratio | 0.333 | 0.359 | 0.407 | 0.288 | 0.304 | |
| Financial Leverage Ratio | 3.944 | 4.020 | 4.646 | 4.257 | 4.286 | |
| Working Capital Turnover Ratio | 6.301 | 7.976 | 14.235 | 32.457 | 22.941 | |
| Operating Cash Flow Ratio | 0.533 | -0.360 | -0.839 | -0.300 | -0.167 | |
| Operating Cash Flow Sales Ratio | 0.166 | -0.105 | -0.213 | -0.096 | -0.068 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.304 | 2.041 | 1.457 | 1.718 | 1.993 | |
| Debt Service Coverage Ratio | 1.696 | 4.041 | 1.531 | 2.131 | 0.995 | |
| Interest Coverage Ratio | 6.039 | 8.601 | 3.735 | 1.972 | -1.165 | |
| Short Term Operating Cash Flow Coverage Ratio | 2.432 | -2.397 | -3.003 | -1.807 | -0.405 | |
| Operating Cash Flow Coverage Ratio | 0.471 | -0.293 | -0.572 | -0.408 | -0.163 | |
| Capital Expenditure Coverage Ratio | 1.437 | -0.961 | -2.189 | -1.393 | -1.007 | |
| Dividend Paid And Capex Coverage Ratio | 1.233 | -0.819 | -1.901 | -1.256 | -0.423 | |
| Dividend Payout Ratio | 0.210 | 0.118 | 0.226 | -1.156 | -8.937 | |
| Enterprise Value Multiple | 23.131 | 10.879 | 11.049 | 11.511 | 5.624 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 75.8% | ▲50.4% | ▲48.4% |
| Ebit Margin | 15.8% | ▼-2.4% | ▲6.0% |
| Ebitda Margin | 19.6% | ▼-10.0% | ▲0.1% |
| Operating Profit Margin | 12.1% | ▼-6.4% | ▲4.6% |
| Pretax Profit Margin | 13.8% | ▼-5.4% | ▲5.5% |
| Continuous Operations Profit Margin | 9.1% | ▼-6.8% | ▲3.0% |
| Net Profit Margin | 9.1% | ▼-6.8% | ▲3.1% |
| Bottom Line Profit Margin | 9.1% | ▼-6.8% | ▲3.1% |
| Current Ratio | 1.526 | ▼-0.049 | ▲0.204 |
| Quick Ratio | 1.307 | ▼-0.033 | ▲0.195 |
| Solvency Ratio | 0.078 | ▼-0.086 | ▼-0.017 |
| Cash Ratio | 0.472 | ▲0.030 | ▲0.254 |
| Price To Earnings Ratio | 47.739 | ▲28.940 | ▲78.505 |
| Price To Earnings Growth Ratio | -1.262 | ▼-1.400 | ▼-2.719 |
| Forward Price To Earnings Growth Ratio | -1.262 | ▼-1.400 | ▼-2.719 |
| Price To Earnings Diluted Ratio | 47.739 | ▲28.940 | ▲78.496 |
| Price To Earnings Diluted Growth Ratio | -1.262 | ▼-1.399 | ▼-2.719 |
| Price To Book Ratio | 7.617 | ▲2.264 | ▲3.574 |
| Price To Sales Ratio | 4.331 | ▲1.341 | ▲2.192 |
| Price To Free Cash Flow Ratio | 85.849 | ▲99.862 | ▲74.887 |
| Price To Operating Cash Flow Ratio | 26.097 | ▲54.696 | ▲32.476 |
| Debt To Assets Ratio | 0.157 | ▼-0.002 | ▼-0.001 |
| Debt To Equity Ratio | 0.619 | ▼-0.019 | ▼-0.053 |
| Debt To Capital Ratio | 0.383 | ▼-0.007 | ▼-0.017 |
| Long Term Debt To Capital Ratio | 0.333 | ▼-0.026 | ▼-0.005 |
| Financial Leverage Ratio | 3.944 | ▼-0.076 | ▼-0.287 |
| Working Capital Turnover Ratio | 6.301 | ▼-1.675 | ▼-10.481 |
| Operating Cash Flow Ratio | 0.533 | ▲0.893 | ▲0.760 |
| Operating Cash Flow Sales Ratio | 0.166 | ▲0.271 | ▲0.229 |
| Free Cash Flow Operating Cash Flow Ratio | 0.304 | ▼-1.737 | ▼-1.199 |
| Debt Service Coverage Ratio | 1.696 | ▼-2.346 | ▼-0.383 |
| Interest Coverage Ratio | 6.039 | ▼-2.562 | ▲2.203 |
| Short Term Operating Cash Flow Coverage Ratio | 2.432 | ▲4.829 | ▲3.468 |
| Operating Cash Flow Coverage Ratio | 0.471 | ▲0.764 | ▲0.664 |
| Capital Expenditure Coverage Ratio | 1.437 | ▲2.397 | ▲2.259 |
| Dividend Paid And Capex Coverage Ratio | 1.234 | ▲2.052 | ▲1.867 |
| Dividend Payout Ratio | 0.210 | ▲0.091 | ▲2.117 |
| Enterprise Value Multiple | 23.131 | ▲12.252 | ▲10.692 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $110.57B | $70.47B | $37.76B | $28.28B | $13.72B | |
| Enterprise value | $115.82B | $75.86B | $46.65B | $33.62B | $21.41B | |
| EV / Sales | 4.54x | 3.22x | 1.87x | 1.38x | 1.09x | |
| EV / Op. cash flow | 27.34x | -30.79x | -8.80x | -14.29x | -16.00x | |
| EV / Free cash flow | 89.92x | -15.08x | -6.04x | -8.32x | -8.03x | |
| EV / EBITDA | 23.13x | 10.88x | 11.05x | 11.51x | 5.62x | |
| Net debt / EBITDA | 1.05x | 0.77x | 2.11x | 1.83x | 2.02x | |
| Current ratio | 1.53x | 1.57x | 1.31x | 1.19x | 1.00x | |
| Income quality | 1.83x | -0.66x | -3.27x | 14.09x | 6.53x | |
| Graham number | $88 | $106 | $62 | — | — | |
| Graham net-net | -$110 | -$104 | -$112 | -$97 | -$103 | |
| Tax burden | 66.0% | 83.1% | 66.6% | 28.8% | -144.4% | |
| Interest burden | 87.3% | 105.6% | 142.6% | -112.3% | 11.6% | |
| Working capital | $4.17B | $3.93B | $1.98B | $1.52B | -$15.0M | |
| Invested capital | $27.07B | $25.59B | $24.52B | $21.39B | $19.60B | |
| Return on assets | 4.1% | 7.1% | 3.2% | -0.3% | -0.4% | |
| Operating ROA | 5.6% | 8.4% | 3.3% | 1.0% | -0.7% | |
| Return on tangible assets | 4.1% | 7.1% | 3.2% | -0.3% | -0.4% | |
| Return on equity | 16.0% | 28.5% | 14.9% | -1.5% | -1.8% | |
| Return on invested capital | 4.0% | 7.7% | 2.3% | 0.4% | 0.5% | |
| Return on capital employed | 6.3% | 9.4% | 3.6% | 1.3% | -0.9% | |
| Earnings yield | 2.1% | 5.3% | 4.3% | -0.6% | -1.5% | |
| Free cash flow yield | 1.2% | -7.1% | -20.5% | -14.3% | -19.4% | |
| Capex / Op. cash flow | 69.6% | -104.1% | -45.7% | -71.8% | -99.3% | |
| Capex / Depreciation | 113.4% | 95.0% | 96.3% | 69.6% | 33.3% | |
| Capex / Sales | 11.5% | 10.9% | 9.7% | 6.9% | 6.8% | |
| SG&A / Sales | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.0% | 0.0% | 0.5% | 0.2% | |
| Intangibles / Total assets | 0.7% | 0.8% | 0.8% | 0.1% | 0.0% | |
| Days sales outstanding | 61d | 58d | 42d | 50d | 45d | |
| Days payables outstanding | 0d | 0d | 0d | 46d | 38d | |
| Operating cycle | 164d | 91d | 67d | 74d | 73d | |
| Cash conversion cycle | 164d | 91d | 67d | 28d | 35d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-06-12 | John Boozman | Buy | $1,001 - $15,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve | Sale | $15,001 - $50,000 |
| 2025-05-08 | Jefferson Shreve | Purchase | $15,001 - $50,000 |
| 2025-04-01 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-03-31 | Jefferson Shreve | Sale | $15,001 - $50,000 |
| 2025-02-12 | Julie Johnson | Purchase | $1,001 - $15,000 |
| 2023-03-01 | Daniel Goldman | Purchase | $1,001 - $15,000 |
| 2023-01-31 | Daniel Goldman | Sale | $1,001 - $15,000 |
Recent news
- 2026-08-16 3 Nuclear Energy Stocks Riding the AI Power Surge in August Artificial intelligence workloads are pulling forward a decade of electricity demand growth, and nuclear power is emerging as the always-on backbone hyperscalers actually want to buy.
- 2026-08-15 Why Data Centers Are Turning Energy Stocks Into AI Plays Energy stocks are becoming key players as data center energy demand explodes.
- 2026-08-14 Dividend Champion, Contender, And Challenger Highlights: Week August 16 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 2026-08-13 Is CEG''s Nuclear Fleet Positioned to Support Long-Term Growth? Constellation Energy expands long-term nuclear contracts, license extensions and uprates as carbon-free power demand rises.
- 2026-08-13 4 Nuclear Stocks Riding the AI Power Boom Into 2027 and Beyond Oklo recently acquired Atomic Alchemy, which will expand the company''s capabilities beyond selling SMRs. As the second-largest uranium miner, Cameco is the force fueling the nuclear industry recovery.
- 2026-08-11 Constellation Energy: Higher Guidance And Nuclear Scarcity Are Starting To Pay Off I''m reiterating Constellation Energy as a Strong Buy with a raised price target of $449. AI-driven power demand is translating into long-duration nuclear contracts, with 920 MW of new agreements and 1,100 MW of potential uprates providing significant forward optionality. Calpine''s earnings contribution and aggressive share repurchases are accelerating EPS growth, supporting a 20%+ base EPS CAGR through 2029 and reducing dilution risk.
- 2026-08-09 The Mag 7''s $10 Trillion Blind Spot Tom Yeung here with your Sunday Digest . Imagine that you own a Formula One race car.
- 2026-08-07 Constellation Signed 920 Megawatts of New Power Deals, Including a Walmart PPA. Here''s What It Means for CEG Stock. Constellation Energy just raised its guidance for fiscal year 2026. The power and nuclear energy giant has made crucial progress on a major contract.
- 2026-08-07 CEG Q2 Earnings Call Focuses on Higher Guidance and Nuclear Deals Constellation lifts 2026 earnings guidance as Calpine accretion, nuclear contracting and Crane progress strengthen its growth outlook.
- 2026-08-07 Constellation Energy: The Nuclear Fleet Cash Machine Is Just Waking Up Constellation Energy is rated BUY, with fair valuation, strong fundamentals, and a robust long-term growth outlook driven by AI-driven electricity demand. Constellation Energy''s acquisition of Calpine creates a hybrid nuclear-gas fleet, enhancing operational flexibility and profitability as data centers drive base load demand. The fully amortized nuclear fleet, with extended licenses, acts as a cash flow generator, benefiting directly from rising electricity prices and contract renewals.